Pulmotect
Houston
About Pulmotect
Pulmotect is a biopharma company that develops products that boost the innate immune system to protect against a wide range of lung infections. Its technology stimulates the body’s natural defenses to provide safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded in 2007 and is headquartered in Houston, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $32.1M
- Last round: Debt Financing (Jun 2023)
- Website: pulmotect.com
- Phone: 7135799226
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pulmotect-34022 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.